Article Correctness Is Author's Responsibility: Concept Clearance » Renewal of the Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders

The article below may contain offensive and/or incorrect content.

The goal of this initiative is to encourage the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging to study the pathophysiology and treatment of brain disorders.